Octavius Fenofibrate Octavius Fenofibrate

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Tox21_300151 on PharmaCompass.com

    Client Email Product

    Tox21_300151

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    70
    US DMFs Filed

    US DMFs Filed

    29
    CEP/COS Certifications

    CEP/COS Certifications

    16
    JDMFs Filed

    JDMFs Filed

    4
    Other Certificates

    Other Certificates

    16
    Other Suppliers

    Other Suppliers

    41
    API REF. PRICE (USD / KG)
    74

    API Market Place

    22
    INTERMEDIATES
    5
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    129
    Europe

    Europe

    40
    Canada

    Canada

    12
    Australia

    Australia

    26
    South Africa

    South Africa

    2
    Uploaded Dossiers

    Uploaded Dossiers

    51
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    3,156.00

    Annual Reports

    0

    FDF Market Place

    5
    EXCIPIENTS
    347
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    28

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    57
    REF STANDARD

    EDQM

    4

    USP

    4

    JP

    0

    Other Listed Suppliers

    5
    SERVICES
    1
    left grey arrow
    right gray arrow
    • TABLET;ORAL - 160MG
    • CAPSULE;ORAL - 150MG
    • CAPSULE;ORAL - 50MG
    • TABLET;ORAL - 145MG
    • TABLET;ORAL - 48MG
    • CAPSULE;ORAL - 130MG
    • CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • CAPSULE;ORAL - 43MG
    • CAPSULE;ORAL - 90MG
    • TABLET;ORAL - 105MG
    • TABLET;ORAL - 35MG
    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7915247
    2027-08-20
    U-1059
    22418
    ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA
    1
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7569612
    2027-08-20
    U-1000
    22418
    ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS
    1
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7915247
    2027-08-20
    U-1059
    22418
    ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA
    2
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7741374
    2027-08-20
    U-1060
    22418
    ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH ELEVATED CHOLESTEROL AND/OR LIPID LEVELS
    2
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7569612
    2027-08-20
    U-1000
    22418
    ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS
    2
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7915247
    2027-08-20
    U-1061
    22418
    ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA
    1
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7741374
    2027-08-20
    U-1060
    22418
    ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH ELEVATED CHOLESTEROL AND/OR LIPID LEVELS
    1
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7741373
    2027-08-20
    U-1059
    22418
    ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA
    1
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7915247
    2027-08-20
    U-1000
    22418
    ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS
    2
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7741374
    2027-08-20
    U-1061
    22418
    ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA
    2
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7915247
    2027-08-20
    U-1000
    22418
    ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS
    1
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7741373
    2027-08-20
    U-1059
    22418
    ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA
    2
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7915247
    2027-08-20
    U-1061
    22418
    ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA
    2
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    ATHENA

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    7741374
    2027-08-20
    U-1061
    22418
    ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA
    1
    Athena Company Banner

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    LUPIN

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    8026281
    2025-04-22
    U-1448
    21695
    TREATING SEVERE HYPERTRIGLYCERIDEMIA
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    LUPIN

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    9314447
    Y
    2033-05-31
    U-1447
    21695
    TREATING PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    LUPIN

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    9314447
    Y
    2033-05-31
    U-1448
    21695
    TREATING SEVERE HYPERTRIGLYCERIDEMIA
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    LUPIN

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    8026281
    2025-04-22
    U-1448
    21695
    TREATING SEVERE HYPERTRIGLYCERIDEMIA
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    LUPIN

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    8026281
    2025-04-22
    U-1447
    21695
    TREATING PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    LUPIN

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    8026281
    2025-04-22
    U-1447
    21695
    TREATING PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    9173847
    Y
    2024-10-01
    22118
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    7658944
    Y
    2024-12-09
    22118
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    8124125
    Y
    2024-10-01
    U-1234
    22118
    FOR REDUCING TOTAL CHOLESTEROL (TOTAL-C), LDL-C, APO-LIPOPROTEIN B, OR TOTAL TRIGLYCERIDES, AND TREATING HYPERTRIGLYCERIDEMIA
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    9173847
    Y
    2024-10-01
    22118
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    7658944
    Y
    2024-12-09
    22118
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    8481078
    Y
    2024-10-01
    U-1416
    22118
    USE OF FENOFIBRATE FOR REDUCING ELEVATED TOTAL CHOLESTEROL (TOTAL-C), LDL-C, APO-LIPOPROTEIN B, OR TOTAL TRIGLYCERIDES
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    8481078
    Y
    2024-10-01
    U-1416
    22118
    USE OF FENOFIBRATE FOR REDUCING ELEVATED TOTAL CHOLESTEROL (TOTAL-C), LDL-C, APO-LIPOPROTEIN B, OR TOTAL TRIGLYCERIDES
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    FENOFIBRATE

    PDF Supplier PDF
    URL Supplier Web Content
    8124125
    Y
    2024-10-01
    U-1234
    22118
    FOR REDUCING TOTAL CHOLESTEROL (TOTAL-C), LDL-C, APO-LIPOPROTEIN B, OR TOTAL TRIGLYCERIDES, AND TREATING HYPERTRIGLYCERIDEMIA
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Athena Fenofibrate

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search